Johnson & Johnson's Fiscal Year is From January To December - All Figures are in Percent.
The item "Return-On-Equity" stands at 32.69 percent as of 09/30/2025, the highest value since 09/30/2024.
As of the end of Johnson & Johnson's third quarter, the item "Return On Equity" stands at 32.69 Percent. This represents an increase of 2.30 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.75 percentage points compared to the value the year prior.
The 1 year change in percentage points is 11.75.
The 3 year change in percentage points is 7.12.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Return On Equity | 905,699,262,464.00 |
![]() | AbbVie Inc - Return On Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Return On Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Return On Equity | 280,205,508,085.11 |
![]() | Novartis AG - Return On Equity | 255,096,620,580.91 |